Biosimilar NewsLatest News On Biosimilar Drug Makers And Payers To Blame For Biosimilar Barriers In U.S. Market9/4/2025 3:52 PM Access To Cheaper Biosimilars Varies Across Pharmacy Benefit Managers3/5/2025 7:28 AM FDA Approves Celltrion's Steqeyma as a Biosimilar to Stelara12/19/2024 12:34 AM Overturning Chevron Doctrine Could Impact Medicare’s Drug Selections For Price Negotiations11/14/2024 1:22 PM Rebate Game Played By PBMs And Drug Makers Limits Biosimilar Competition11/10/2024 11:38 AM Blue Shield Of California Push For Cheaper Biosimilars Could Disrupt Market11/6/2024 4:53 PM Biosimilars Are Making Inroads In U.S., But It’s Still A Bumpy Ride11/4/2024 3:58 PM GoodRx teams with Boehringer on Humira biosimilar7/18/2024 5:16 AM Bipartisan Efforts To Legislate Pharmaceutical Patent Reform Heat Up6/3/2024 5:20 AM Switching to Biosimilar Does Not Affect Clinical Remission in IBD Patients11/14/2023 5:00 PM